Epcoritamab-bysp

Epcoritamab-bysp
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rithish Nimmagadda,MBBS.[2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Epcoritamab-bysp is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Epcoritamab-bysp FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Epcoritamab-bysp FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Contraindications

There is limited information regarding Epcoritamab-bysp Contraindications in the drug label.

Warnings

There is limited information regarding Epcoritamab-bysp Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Epcoritamab-bysp Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Epcoritamab-bysp Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Epcoritamab-bysp Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Epcoritamab-bysp in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Epcoritamab-bysp in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Epcoritamab-bysp during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Epcoritamab-bysp in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Epcoritamab-bysp in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Epcoritamab-bysp in geriatric settings.

Gender

There is no FDA guidance on the use of Epcoritamab-bysp with respect to specific gender populations.

Race

There is no FDA guidance on the use of Epcoritamab-bysp with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Epcoritamab-bysp in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Epcoritamab-bysp in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Epcoritamab-bysp in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Epcoritamab-bysp in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Epcoritamab-bysp Administration in the drug label.

Monitoring

There is limited information regarding Epcoritamab-bysp Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Epcoritamab-bysp and IV administrations.

Overdosage

There is limited information regarding Epcoritamab-bysp overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Epcoritamab-bysp Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Epcoritamab-bysp Mechanism of Action in the drug label.

Structure

There is limited information regarding Epcoritamab-bysp Structure in the drug label.

Pharmacodynamics

There is limited information regarding Epcoritamab-bysp Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Epcoritamab-bysp Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Epcoritamab-bysp Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Epcoritamab-bysp Clinical Studies in the drug label.

How Supplied

There is limited information regarding Epcoritamab-bysp How Supplied in the drug label.

Storage

There is limited information regarding Epcoritamab-bysp Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Epcoritamab-bysp |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Epcoritamab-bysp |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Epcoritamab-bysp Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Epcoritamab-bysp interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Epcoritamab-bysp Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Epcoritamab-bysp Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.